You are here: Industry Insights > GSK

News List

UK strikes deal with GSK and Sanofi for 60 mn doses of COVID-19 vaccine expresspharma
July 30, 2020
The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous agreements.
Sanofi and GSK to supply Covid-19 vaccine doses to UK pharmaceutical-technology
July 30, 2020
Sanofi and GlaxoSmithKline (GSK) have signed an agreement with the UK Government to supply up to 60 million doses of a potential Covid-19 vaccine.
GSK Pharma announces results for the quarter ended June 30, 2020 expresspharma
July 30, 2020
GlaxoSmithKline Pharmaceuticals declared its financial results for the quarter ended June 30, 2020. Revenue for the quarter came in at Rs 649 crores as against Rs 787.97 crores for the same period last year.
Sanofi/GSK sign deal with UK gov for COVID-19 vaccine pharmatimes
July 29, 2020
Sanofi and GSK have reached an agreement with the UK government for the supply of up to 60 million doses of their COVID-19 vaccine.
Bora Adds Four Business Development Directors contractpharma
July 24, 2020
Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO) which specializes in immediate and modified release tablets and capsules, along with serialized packaging, has appointed four business development directors..
Orchard Announces Global License Agreements for Stable Cell Line Technology from GSK americanpharmaceuticalreview
July 23, 2020
Orchard Therapeutics announced the company has entered into two worldwide royalty-bearing license agreements with GlaxoSmithKline (GSK).
GSK Buys 10% Stake in German Vaccine Developer CureVac contractpharma
July 22, 2020
Companies will collaborate on the research and development mRNA vaccine candidates.
GSK to obtain 10% stake in vaccines maker CureVac for $163m pharmaceutical-technology
July 21, 2020
GlaxoSmithKline (GSK) has signed an agreement with German company CureVac to research, develop, manufacture and commercialise up to five mRNA-based vaccines and monoclonal antibodies (mAbs) against infectious diseases.
FDA committee backs GSK's multiple myeloma drug pharmatimes
July 15, 2020
GlaxoSmithKline's belantamab mafodotin has been backed for approval to treat relapsed/refractory multiple myeloma by the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC).
GSK, Medicago Enter COVID-19 Vax Tie-up contractpharma
July 14, 2020
Combines plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page